Cargando…

Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models

Breast cancer is one of the major causes of mortality in women worldwide. The most aggressive breast cancer subtypes are human epidermal growth factor receptor-positive (HER2(+)) and triple-negative breast cancers. Therapies targeting HER2 receptors have significantly improved HER2(+) breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padmanabhan, Regina, Kheraldine, Hadeel Shafeeq, Meskin, Nader, Vranic, Semir, Al Moustafa, Ala-Eddin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139939/ https://www.ncbi.nlm.nih.gov/pubmed/32164163 http://dx.doi.org/10.3390/cancers12030636

Ejemplares similares

Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor
por: Padmanabhan, Regina, et al.
Publicado: (2022)

Elaeagnus angustifolia Plant Extract Inhibits Epithelial-Mesenchymal Transition and Induces Apoptosis via HER2 Inactivation and JNK Pathway in HER2-Positive Breast Cancer Cells
por: Jabeen, Ayesha, et al.
Publicado: (2020)

High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions
por: Allouch, Soumaya, et al.
Publicado: (2020)

The Effect of Surface-Modified Gold Nanorods on the Early Stage of Embryonic Development and Angiogenesis: Insight into the Molecular Pathways
por: Mahmoud, Nouf N., et al.
Publicado: (2021)

Novel Nitrogen-Based Chalcone Analogs Provoke Substantial Apoptosis in HER2-Positive Human Breast Cancer Cells via JNK and ERK1/ERK2 Signaling Pathways
por: Rizeq, Balsam, et al.
Publicado: (2021)

Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
por: Kheraldine, Hadeel, et al.
Publicado: (2021)

PD-L1 testing by immunohistochemistry in immuno-oncology
por: Vranic, Semir, et al.
Publicado: (2023)

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
por: Gupta, Ishita, et al.
Publicado: (2020)

A review of mathematical model-based scenario analysis and interventions for COVID-19()
por: Padmanabhan, Regina, et al.
Publicado: (2021)

Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis
por: López-Ozuna, Vanessa M., et al.
Publicado: (2020)

PD-L1 Status in Refractory Lymphomas
por: Vranic, Semir, et al.
Publicado: (2016)

Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways
por: Gupta, Ishita, et al.
Publicado: (2021)

Human Papillomaviruses and Epstein–Barr Virus Interactions in Colorectal Cancer: A Brief Review
por: Fernandes, Queenie, et al.
Publicado: (2020)

Implications of Gut Microbiota in Epithelial–Mesenchymal Transition and Cancer Progression: A Concise Review
por: Gupta, Ishita, et al.
Publicado: (2022)

Fascin in Gynecological Cancers: An Update of the Literature
por: Gupta, Ishita, et al.
Publicado: (2021)

The Role of Epstein–Barr Virus in Cervical Cancer: A Brief Update
por: Vranic, Semir, et al.
Publicado: (2018)

Epstein–Barr Virus in Gliomas: Cause, Association, or Artifact?
por: Akhtar, Saghir, et al.
Publicado: (2018)

PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
por: Cantero-Cid, Ramón, et al.
Publicado: (2018)

Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency
por: Perrichet, Anaïs, et al.
Publicado: (2020)

Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
por: Sareyeldin, Rasha M., et al.
Publicado: (2019)

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
por: Gupta, Ishita, et al.
Publicado: (2020)

Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
por: Yun, Tian, et al.
Publicado: (2020)

Epstein–Barr Virus and Human Papillomaviruses Interactions and Their Roles in the Initiation of Epithelial–Mesenchymal Transition and Cancer Progression
por: Cyprian, Farhan S., et al.
Publicado: (2018)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype
por: Allouch, Soumaya, et al.
Publicado: (2020)

Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
por: Malki, Ahmed, et al.
Publicado: (2020)

Copresence of High-Risk Human Papillomaviruses and Epstein–Barr Virus in Colorectal Cancer: A Tissue Microarray and Molecular Study from Lebanon
por: Nagi, Karim, et al.
Publicado: (2021)

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1
por: Gatalica, Zoran, et al.
Publicado: (2015)

Co-Incidence of Epstein–Barr Virus and High-Risk Human Papillomaviruses in Cervical Cancer of Syrian Women
por: Al-Thawadi, Hamda, et al.
Publicado: (2018)

Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
por: Lin, Weimin, et al.
Publicado: (2018)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Co-incidence of Human Papillomaviruses and Epstein–Barr Virus Is Associated With High to Intermediate Tumor Grade in Human Head and Neck Cancer in Syria
por: Gupta, Ishita, et al.
Publicado: (2020)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2021)

Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes
por: Nascimento, Catarina, et al.
Publicado: (2020)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
por: Diggs, Laurence P., et al.
Publicado: (2017)

High-risk human papillomaviruses and Epstein–Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study
por: Nagi, Karim, et al.
Publicado: (2021)

Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer
por: Gupta, Ishita, et al.
Publicado: (2021)

PD-1/PD-L1 Inhibitors in Cervical Cancer
por: Liu, Yuncong, et al.
Publicado: (2019)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bbmhda4qunfm3eb543ukkna7s3